MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Fatty Acid Metabolic Reprogramming Regulates Glial-Epithelial Axis via Nur77 Palmitoylation in Intestinal Dysfunction in Parkinson’s Disease

    J. Zou, Z. Deng, Z. Lu, X. Luo, F. Yu, W. Bi (Guangzhou, China)

    Objective: This study aims to elucidate the regulatory role of stearoyl-CoA desaturase 1 (SCD1) in Parkinson’s disease (PD)-associated intestinal dysfunction, focusing on its mechanism in…
  • 2025 International Congress

    Transcranial sonography in Parkinson’s disease patients

    D. Khasanova, I. Khasanov, Z. Zalyalova (Kazan, Russian Federation)

    Objective: To present the usage and results of transcranial sonography (TCS) in Parkinson's disease (PD) patients. Background: (TCS) has emerged as a valuable diagnostic tool…
  • 2025 International Congress

    Dopaminergic and Synaptic Alterations in SWEDD: Insights from [¹⁸F] FE-PE2I and [¹¹C] UCB-J PET Imaging

    F. Ebrahimian Sadabad, T. Volpi, P. Honhar, L. Colon, S. Tinaz, M. Naganawa, M. Dias, G. Angarita, R. Comley, R. Carson, S. Finnema, D. Matuskey (Tallahassee, USA)

    Objective: To investigate dopaminergic and synaptic density in SWEDD patients compared to idiopathic Parkinson’s disease (IPD) and healthy controls (HCs). Background: Scans Without Evidence of…
  • 2025 International Congress

    Glial interaction with Parkinsonian disorders biomarkers: alpha-synuclein, dopaminergic dysfunction and clinical stages

    L. Souza, D. Teixeira, G. Pereira, E. Zimmer, W. Borelli, A. Schuh (Porto Alegre, Brazil)

    Objective: We aim to investigated the relationship between glial markers and Parkinson's disease. Background: Neuronal α-Synuclein Disease (NSD) has recently been proposed as a framework for…
  • 2025 International Congress

    Subthalamic nucleus DBS outcomes correlate with white matter tractography in Parkinson’s Disease

    I. Campbell, V. Del Bene, R. Martin, C. Gonzalez, S. Brinkerhoff, M. Wade, B. Hill, H. Walker, V. Mishra (Mobile, USA)

    Objective: To assess whether advanced diffusion magnetic resonance imaging (dMRI) techniques help to understand the outcome of Deep brain stimulation (DBS) surgery on Unified Parkinson’s…
  • 2025 International Congress

    Incidence and Associated Factors for Phenoconversion of Parkinson’s Disease in the Chinese Community Older Adults with LRRK2 G2385R and R1628P Variants

    J. Liu, T. Mi, Z. Gu, Y. Li, M. Cao, Z. Ren, H. Zhang, M. Chen, J. Chen, L. Ma, X. Xu, C. Han, L. Zhang, J. An, P. Chan (Beijing, China)

    Objective: To investigate the 10-year accumulated incidence and associated factors for phenoconversion of Parkinson’s disease (PD) in community older adults carrying LRRK2 G2385R or/and R1628P variants. Background: Previous…
  • 2025 International Congress

    Detection and classification of Parkinson’s disease from neuroimaging modalities using machine learning and artificial intelligence: a systematic review

    F. Ebrahimian Sadabad, P. Honhar, S. Houshi, F. Nejati, S. Bagherieh, A. Brackett, F. Yazdanpanah, S. Cayir, M. Hosseini, H. Tagare, D. Matuskey (New Haven, USA)

    Objective: This systematic review evaluates performance of machine learning (ML) and artificial intelligence (AI) techniques applied to neuroimaging modalities in differentiating Parkinson’s disease (PD) patients…
  • 2025 International Congress

    Semi-quantitative Evaluation of Midbrain Accumulation in 123I-FP-CIT SPECT in Parkinson’s disease and Parkinsonian Syndromes

    T. Totsune, T. Baba, Y. Sugimura, H. Oizumi, H. Tanaka, T. Takahashi, M. Yoshioka, K. Nagamatsu, T. Hasegawa, A. Takeda (Sendai, Japan)

    Objective: To establish a method for evaluating midbrain accumulation of 123I-FP-CIT SPECT and assess its ability to differentiate between Parkinson’s disease (PD) and Parkinsonian syndromes…
  • 2025 International Congress

    Alpha-Synuclein Accumulation-Attenuating Effect of Brain-Derived Neurotrophic Factor in Primary Cell Culture Model of Parkinson’s Disease

    I. Hlushchuk, MT. Airavaara (Helsinki, Finland)

    Objective: To explore the role of neurotrophic signaling pathways in modulating the effect of brain-derived neurotrophic factor (BDNF) on pre-formed fibrils (PFFs)- induced alpha-synuclein (aSyn)…
  • 2025 International Congress

    Alterations of Plasma Membrane in Parkinson’s disease LRRK2 I1371V iPSC derived Astrocytes contribute to the vulnerability of the niche cells to Extracellular α-Synuclein

    I. Datta, R. Banerjee, V. Holla, N. Kamble, R. Yadav, P. Pal (Bengaluru, India)

    Objective: This study investigates the impact of LRRK2 I1371V mutation on astrocyte plasma membrane dynamics & its association with extracellular α-synuclein using astrocytes derived from…
  • « Previous Page
  • 1
  • …
  • 174
  • 175
  • 176
  • 177
  • 178
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley